한글목차

세계 동물 의약품 시장은 2018년 232억 9,310만 달러로 평가되었으며, 2023년까지 연평균 5.0% 이상 성장할 것으로 예상됩니다.

반려동물 인구 증가

반려동물 인구 증가는 실적 기간 동안 동물 의약품 시장의 성장을 주도했습니다. 전 세계 반려동물 인구 증가는 수의사 진료 건수 증가를 의미합니다. 전 세계 수의학계는 반려동물 사육 증가와 동물 복지를 고려한 진료의 채택 등 큰 변화를 겪고 있으며, 이는 동물 의약품에 대한 수요를 더욱 증가시키고 있습니다. 예를 들어, 2021년 7월 미국 기반 컨설팅 산업 플랫폼인 Consulting.US에 따르면 미국의 반려견과 반려묘 수는 2019년 1억 4,000만 마리에서 2020년 1억 4,900만 마리로 증가해 약 7%의 성장률을 보였습니다. 또한 미국 비영리단체인 미국 수의사협회에 따르면 2020년에는 45%의 가구가 개를 키우게 될 것이며, 이는 2016년 말 38%에서 증가한 수치입니다. 지난해 반려견 인구는 8,370만-8,890만 마리로 추산되며 2016년 말 대비 9%-16% 증가했습니다. 또한 중국반려동물산업협회에 따르면 2021년 도시지역 반려견과 반려묘의 수는 2020년 1억 800만 마리를 넘어 2019년 대비 1.7% 증가했으며, 2022년 미국인들은 반려동물에 1,368억 달러를 지출해 2021년(1,236억 달러)보다 10.68% 증가할 것으로 예상했습니다. 증가했습니다. 따라서 반려동물 인구 증가는 동물 의약품 시장의 성장을 뒷받침했습니다.

목차

제1장 주요 요약

• 동물 의약품 - 시장의 매력과 거시경제 상황

제2장 목차

제3장 표 리스트

제4장 그래프 리스트

제5장 보고서 구성

제6장 시장 특징

• 일반적인 시장의 정의
• 개요
• 동물 의약품 시장 정의와 세분화
• 시장 세분화 : 유형별
  • 수의용 백신
  • 수의용 항생제
  • 수의용 구충제
  • 기타 동물 의약품
• 시장 세분화 : 동물 유형별
  • 가축
  • 반려동물
• 시장 세분화 : 백신 유형별
  • 불활화 백신
  • 약독화 백신
  • 재조합 백신
  • 기타 백신
• 시장 세분화 : 투여 경로별
  • 경구
  • 비경구
  • 외용약
  • 기타 투여 경로
• 시장 세분화 : 최종사용자별
  • 동물 병원
  • 수의 클리닉
  • 약국/드럭스토어

제7장 주요 시장 동향

제8장 동물 의약품 시장 : 거시경제 시나리오

• COVID-19의 영향 : 동물 의약품 시장
• 우크라이나 전쟁의 영향 : 동물 의약품 시장
• 고인플레이션의 영향 : 동물 의약품 시장

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023
  • 시장 성장 촉진요인, 2018-2023
  • 시장 성장 억제요인, 2018-2023
• 시장 성장 예측, 2023-2028, 2033년
  • 시장 성장 촉진요인, 2023-2028
  • 시장 성장 억제요인, 2023-2028

제10장 세계의 동물 의약품 시장 : 세분화

• 세계의 동물 의약품 시장 : 유형별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 동물 의약품 시장 : 동물 유형별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 동물 의약품 시장 : 백신 유형별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 동물 의약품 시장 : 투여 경로별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 동물 의약품 시장 : 최종사용자별, 분석과 예측, 2018-2023년, 2028년, 2033년

제11장 동물 의약품 시장 : 지역/국가별 분석

• 세계의 동물 의약품 시장 : 지역별, 분석과 예측, 2018-2023년, 2028년, 2033년
• 세계의 동물 의약품 시장 : 국가별, 분석과 예측, 2018-2023년, 2028년, 2033년

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 개요

• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Zoetis Inc.
• Ceva Sante Animale

제20장 기타 주요 기업 및 혁신 기업

• Virbac SA
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC
• Evonik Industries AG
• Zydus Animal Health
• Eco Animal Health
• Animalcare Group
• Neogen Corp
• Phibro Animal Health
• Mobedco-Vet
• ImmuCell Corporation
• Ourofino Saude Animal
• Hipra
• Biogenesis Bago
• Huvepharma

제21장 경쟁 벤치마킹

제22장 경쟁 대시보드

제23장 주요 인수합병(M&A)

• Phibro Animal Health Corporation Acquired Zoetis'
• Merck Animal Health Acquired Elanco Animal Health's
• EQT Acquired Dechra Pharmaceuticals
• Wedgewood Pharmacy Merged With Blue Rabbit
• Sun Pharmaceutical Acquired A Majority Stake In Vivaldis Health and Foods
• Orion Corporation Acquired VMD NV
• Zendal Group Acquired Maymo
• Mitsui Acquired Sumitomo Pharma Animal Health
• Zoetis Acquired Jurox
• Vimian Group Acquired Heiland GmbH
• Dechra Acquired Med-Pharmex
• Bimeda Acquired Afrivet
• Dechra Pharmaceuticals Acquired Piedmont Animal Health
• Virbac Acquired Assets Of Elanco Animal Health Inc.
• Vetoquinol Acquired Australian Assets Of Elanco Animal Health Inc.

제24장 기회와 전략

• 세계의 동물 의약품 시장(2028년) : 새로운 기회를 제공하는 국가
• 세계의 동물 의약품 시장(2028년) : 새로운 기회를 제공하는 부문
• 세계의 동물 의약품 시장(2028년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제25장 동물 의약품 시장 : 결론과 제안

• 결론
• 제안
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제26장 부록

영문목차

Veterinary pharmaceuticals or veterinary drugs are drugs that are intended for use in animals in the case of disease or illness. These products achieve their effect through pharmacological actions in the animal body.

The veterinary pharmaceuticals market consists of sales of veterinary pharmaceuticals by entities (organizations, sole traders and partnerships) that manufacture veterinary pharmaceuticals (or drugs) used to sedate, treat animal diseases and/or to improve animals' performance and health. The veterinary pharmaceuticals industry includes establishments that manufacture veterinary pharmaceuticals such as veterinary vaccines, veterinary antibiotics and other veterinary pharmaceuticals.

The global veterinary pharmaceuticals market was valued at $23,293.1 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 5.0%.

Increased Pet Population

The increase in the pet population drove the growth of the veterinary pharmaceuticals market during the historic period. A growing global pet population means an increase in veterinary caseloads. The global veterinary community is going through an enormous shift-change, with increasing pet ownership and the adoption of good animal welfare practices, thus further increasing demand for veterinary pharmaceuticals. For instance, in July 2021, according to Consulting.US, a US-based consulting industry platform, the number of pet dogs and cats in the USA increased from 140 million in 2019 to 149 million in 2020, representing approximately 7% growth. Also, in 2020, according to the American Veterinary Medical Association, a US-based not-for-profit organization, 45% of households owned dogs, up from 38% at year-end 2016. The population of pet dogs was estimated to be between 83.7 million and 88.9 million last year, up 9%-16% from year-end 2016. Furthermore, in 2021, according to the China Pet Industry Association, the number of pet dogs and cats in urban areas exceeded 100.8 million in 2020, 1.7 % up on 2019. In 2022, Americans spent $136.8 billion on their pets, up 10.68% from 2021 ($123.6 billion). Therefore, the increased pet population supported the growth of the veterinary pharmaceuticals market.

Increased Focus On Stem Cell Therapy To Treat Animals

Stem cell therapy is being increasingly adopted by veterinarians to treat orthopedic conditions such as osteoarthritis, ligament injuries and tendons in high commercial value species, such as racehorses. Stem cell therapy helps to restore motion and stimulate the regeneration of tendon, ligament and joint tissues by isolating adult stem cells from an animals' fat tissue and re-introducing these cells to reduce pain and inflammation. Some of the companies offering stem cell therapy in the USA include VetStem and MediVet. For instance, in April 2022, Boehringer Ingelheim, a German pharmaceutical company, launched RenuTend, a stem cell therapy for horses. It improves healing of tendon and suspensory ligament injuries. It is administered intralesionally, targeting fiber alignment and reducing scar tissue formation, enhancing the quality of healing.

The global veterinary pharmaceuticals market is highly concentrated, with a few large players operating in the market. The top ten competitors in the market made up 60.3% of the total market in 2022.

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for veterinary pharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The veterinary pharmaceuticals market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider veterinary pharmaceuticals market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by type of animal, by type of vaccine, by route of administration and by end-user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the veterinary pharmaceuticals market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by type of animal, by type of vaccine, by route of administration and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for veterinary pharmaceuticals providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type: Veterinary Vaccines; Veterinary Antibiotics; Veterinary Parasiticides; Other Veterinary Pharmaceuticals
• 2) By Type Of Animal: Livestock Animals; Companion Animals
• 3) By Type Of Vaccine: Inactivated Vaccines; Attenuated Vaccines; Recombinant Vaccines; Other Vaccines
• 4) By Route Of Administration: Oral; Parenteral; Topical; Other Routes Of Administration
• 5) By End-User: Veterinary Hospitals; Veterinary Clinics; Pharmacies And Drug Stores
• Companies Mentioned: Merck & Co., Inc.; Boehringer Ingelheim International GmbH; Elanco Animal Health Incorporated; Zoetis Inc; Ceva Sante Animale
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Ontario; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; veterinary pharmaceuticals indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Veterinary Pharmaceuticals - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Veterinary Pharmaceuticals Market Definition And Segmentations
• 6.4 Market Segmentation By Type
  • 6.4.1 Veterinary Vaccines
  • 6.4.2 Veterinary Antibiotics
  • 6.4.3 Veterinary Parasiticides
  • 6.4.4 Other Veterinary Pharmaceuticals
• 6.5 Market Segmentation By Type Of Animal
  • 6.5.1 Livestock Animals
  • 6.5.2 Companion Animals
• 6.6 Market Segmentation By Type Of Vaccine
  • 6.6.1 Inactivated Vaccines
  • 6.6.2 Attenuated Vaccines
  • 6.6.3 Recombinant Vaccines
  • 6.6.4 Other Vaccines
• 6.7 Market Segmentation By Route Of Administration
  • 6.7.1 Oral
  • 6.7.2 Parenteral
  • 6.7.3 Topical
  • 6.7.4 Other Routes Of Administration
• 6.8 Market Segmentation By End-User
  • 6.8.1 Veterinary Hospitals
  • 6.8.2 Veterinary Clinics
  • 6.8.3 Pharmacies And Drug Stores

7 Major Market Trends

• 7.1 Increased Focus On Stem Cell Therapy To Treat Animals
• 7.2 Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
• 7.3 Development Of Chewable Tablets To Improve Convenience In Animals
• 7.4 Use Of Telemedicine Platforms To Improve Access To Care
• 7.5 Development Of Advanced Vaccines To Reduce Disease Burden In Animals
• 7.6 Development Of Super-Combo Parasiticides To Help Control Parasites
• 7.7 Use Of Subunit And Virus-Like Particle (VLP)-Based Vaccines
• 7.8 Strategic Partnerships And Collaborations Among Market Players

8 Veterinary Pharmaceuticals Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Veterinary Pharmaceuticals Market
• 8.2 Impact Of The War In Ukraine On The Veterinary Pharmaceuticals Market
• 8.3 Impact Of High Inflation On The Veterinary Pharmaceuticals Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018-2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Veterinary Pharmaceuticals Market Segmentation

• 10.1 Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.4 Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.5 Global Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Veterinary Pharmaceuticals Market, Regional and Country Analysis

• 11.1 Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.9 China Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 India Market
• 12.12 India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 India Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Australia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Indonesia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 South Korea Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate Tax Structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Veterinary Pharmaceuticals Market: Country Analysis
• 13.6 UK Market
• 13.7 UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Veterinary Pharmaceuticals Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Veterinary Pharmaceuticals Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.9 USA Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Summary
  • 15.12.1 Market Overview
  • 15.12.2 Country Information
  • 15.12.3 Market Information
  • 15.12.4 Background Information
  • 15.12.5 Government Initiatives
  • 15.12.6 Regulations
  • 15.12.7 Regulatory Bodies
  • 15.12.8 Major Associations
  • 15.12.9 Taxes Levied
  • 15.12.10 Corporate Tax Structure
  • 15.12.11 Investments
  • 15.12.12 Major Companies
• 15.13 Canada Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.15 Canada Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.16 Ontario Market
• 15.17 Ontario Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.18 Ontario Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.19 Ontario Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview 250
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Veterinary Pharmaceuticals Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.3 Africa Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Merck & Co., Inc.
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
  • 19.1.3 Business Strategy
  • 19.1.4 Financial Overview
• 19.2 Boehringer Ingelheim International GmbH
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Elanco Animal Health Incorporated
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Zoetis Inc.
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Ceva Sante Animale
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview

20 Other Major And Innovative Companies

• 20.1 Virbac SA
  • 20.1.1 Company Overview
  • 20.1.2 Products And Services
• 20.2 Vetoquinol S.A.
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
• 20.3 Dechra Pharmaceuticals PLC
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
• 20.4 Evonik Industries AG
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
• 20.5 Zydus Animal Health
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
• 20.6 Eco Animal Health
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
• 20.7 Animalcare Group
  • 20.7.1 Company Overview
  • 20.7.2 Products And Services
• 20.8 Neogen Corp
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
• 20.9 Phibro Animal Health
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
• 20.10 Mobedco-Vet
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
• 20.11 ImmuCell Corporation
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
• 20.12 Ourofino Saude Animal
  • 20.12.1 Company Overview
  • 20.12.2 Products And Services
• 20.13 Hipra
  • 20.13.1 Company Overview
  • 20.13.2 Products And Services
• 20.14 Biogenesis Bago
  • 20.14.1 Company Overview
  • 20.14.2 Products And Services
• 20.15 Huvepharma
  • 20.15.1 Company Overview
  • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Phibro Animal Health Corporation Acquired Zoetis'
• 23.2 Merck Animal Health Acquired Elanco Animal Health's
• 23.3 EQT Acquired Dechra Pharmaceuticals
• 23.4 Wedgewood Pharmacy Merged With Blue Rabbit
• 23.5 Sun Pharmaceutical Acquired A Majority Stake In Vivaldis Health and Foods
• 23.6 Orion Corporation Acquired VMD NV
• 23.7 Zendal Group Acquired Maymo
• 23.8 Mitsui Acquired Sumitomo Pharma Animal Health
• 23.9 Zoetis Acquired Jurox
• 23.10 Vimian Group Acquired Heiland GmbH
• 23.11 Dechra Acquired Med-Pharmex
• 23.12 Bimeda Acquired Afrivet
• 23.13 Dechra Pharmaceuticals Acquired Piedmont Animal Health
• 23.14 Virbac Acquired Assets Of Elanco Animal Health Inc.
• 23.15 Vetoquinol Acquired Australian Assets Of Elanco Animal Health Inc.

24 Opportunities And Strategies

• 24.1 Global Veterinary Pharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
• 24.2 Global Veterinary Pharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
• 24.3 Global Veterinary Pharmaceuticals Market In 2028 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Veterinary Pharmaceuticals Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer